Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 42 results for "orchid pharma"

Orchid Chemicals  Pharma Q1 net loss at Rs 47.56 cr
Moneycontrol.com

Orchid Pharma posts net loss at Rs 47.6 crore

Orchid Chemicals and Pharmaceuticals reported a standalone net loss of Rs 47.6 crore for the quarter ended June, against net loss of Rs 60.1 crore for the corresponding period in the previous financial year. Total operating income of the company was ... Business Standard, 2 weeks ago
Orchid Chemicals Pharma Q1 net loss at Rs 47.56 cr Moneycontrol.com, 2 weeks ago
First Post.com

Orchid Chemicals & Pharma zooms 16% in early trade on USFDA nod for generic drug

From its 52-week low level, the stock has so far gained a whopping 35 percent in last one week The post Orchid Chemicals & Pharma zooms 16% in early trade on USFDA nod for generic drug appeared first on Firstpost .
 First Post.com2 months ago Orchid Pharma stock soars on receiving USFDA nod  India Infoline2 months ago Orchid Pharma rallies on getting USFDA nod  India Infoline2 months ago

Stocks in news: Sun Pharma, Cipla, Orchid Chem, MM, Bharti

Sun Pharma | Maruti Suzuki | Cipla | Dhanuka Agritech | Orchid Chemicals | Torrent Pharma | Talwalkars Fitness | NTPC | Mahindra and Mahindra | YES Bank and Bharti Airtel are stocks, which are in the news today.
 Money Control2 months ago

Stocks in news: Wipro, Infosys, Cairn, Tata Motors, DLF

Wipro | Infosys | Tata Steel | Cairn India | Tata Motors | Lupin | Orchid Pharma | Jagran Prakashan | Reliance Infrastructure | Novartis India | Bajaj Finance | DLF | GMR Infrastructure and IndusInd Bank are stocks, which are in the news today.
 Money Control2 months ago

PLIGHT OF INDIAN COS

Financial performances of top 100 pharmaceutical companies during 2014-15 indicate the hard times ahead for this once best performing sector of the Indian economy. The key reason for the poor performance of pharmaceutical companies is due to the ...
 PharmaBiz1 month ago Several pharma cos with sharp drop in sales & profits in 5 years dampen investor's mood  PharmaBiz1 month ago Top 100 pharma cos report 1.8% growth in profit, sales grew by 7% during 2014-15  PharmaBiz1 month ago
Sify

Sensex, Nifty flat amid lackluster trades; IT, pharma stocks post smart gains

The market remains quite sluggish this afternoon, with investors largely refraining from making significant moves. Asian markets mostly ended on a positive note, albeit with marginal gains, while European markets are currently trading slightly lower ...
 Sify1 month ago Sensex down 45 pts amid wild swings as traders look for direction  Sify1 week ago
NDTV

Sensex Falls 324 Points on Weak Rupee, Global Cues

The Sensex plunged 324 points to close at 27,608 and the Nifty fell 122 points to settle at 8,372 after the rupee weakened to near two year low of 65.49 amid weakness in global stock markets. In the intraday deals, the Sensex and Nifty opened on a ...
 NDTV1 week ago Live: Sensex Down Over 300 Points, Nifty Below 8,400  NDTV Profit1 week ago Sensex ends 28 points down, below 28K; Tata Motors slumps 4%, India Cements 4%, NIIT Tech up 11%  Economic Times1 month ago Sensex cracks 600 points as Greek woes loom  Economic Times2 months ago
Livemint.com

Lupin jumps 8%, most in five years

Mumbai: Shares of Lupin Ltd on Thursday posted their biggest gain in five years after media reports suggesting that the company has secured key drug approvals from US Foods and Drugs Administration (FDA). The stock rose as much as 8.08%—the ...
 Livemint.com1 week ago
SleekMoney

Zacks Upgrades Hospira to Buy (HSP)

Hospira (NYSE:HSP) was upgraded by Zacks from a hold rating to a buy rating in a note issued to investors on Friday, Market Beat.com reports. The firm presently has a $100.00 price objective on the stock. Zacks s price target would indicate a ...
 SleekMoney4 weeks ago Hospira Upgraded to Buy at Zacks (HSP)  WKRB News1 month ago

Global clinical trial supply and logistics market to grow at a CAGR of 8.87% over the period 2014-2019.

Clinical trial companies, also known as contact manufactures or CROs, offer development and research, and manufacturing services on a contract basis to pharmaceutical and biotechnology vendors as well as government institutions, foundations, and ...
 TransWorldNews1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less